Journal article · 2017 · Open access

Combined use of electroconvulsive therapy and antipsychotics (both clozapine and non-clozapine) in treatment resistant schizophrenia: A comparative meta-analysis

Saeed Ahmed, Ali Khan, Hema Madhuri Mekala, Hema Venigalla, Rizwan Ahmed, Amira Etman, Michael Esang, Mustafa Qureshi

Heliyon, 3(11), e00429 · Published 1 November 2017 · DOI 10.1016/j.heliyon.2017.e00429

Open full textCite this paper

In brief

“Combined use of electroconvulsive therapy and antipsychotics (both clozapine and non-clozapine) in treatment resistant schizophrenia: A comparative meta-analysis” is a 2017 journal article by Saeed Ahmed and 7 co-authors, published in Heliyon. OpenAlex counts 50 citations as of 20 November 2026, which puts it in the top 7% of works published in 2017 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Heliyon.

Citations
50
Most cited in
2019 (8)
Field-weighted impact
4.01
References
61
Authors
8

Abstract

AIM: To assess the relative efficacies of clozapine plus Electroconvulsive Therapy (ECT) compared against non-clozapine typical and atypical antipsychotics plus ECT for the treatment of "Treatment Resistant Schizophrenia" (TRS). Primarily to assess if clozapine delivers a significant improvement over other antipsychotics when combined with ECT. DESIGN: Major electronic databases were searched between 1990 and March 2017 for trials measuring the effects of either clozapine augmented ECT, other antipsychotic-augmented ECT, or both. After the systematic review of the data, a random-effects meta-analysis was conducted measuring the relative effect sizes of the different treatment regimens. SUBJECTS: 1179 patients in 23 studies reporting the usage of ECT augmentation with antipsychotics. A total of 95 patients were tested with clozapine, and ECT (9 studies) and 1084 patients were tested with non-clozapine antipsychotics (14 studies) such as flupenthixol, chlorpromazine, risperidone, sulpiride, olanzapine, and loxapine with concurrent ECT treatment considered for systematic review. Of these, 13 studies reported pre and post-treatment scores were included in the meta-analysis. MAIN OUTCOME MEASURES: The main outcome measure was the presence and degree of both positive and negative psychotic symptoms, as measured by either of two standardized clinician administered tests, the Brief Psychiatric Rating Scale (BPRS), and the Positive and Negative Symptom Scale (PANSS). RESULTS: The comparison of the different antipsychotics established the supremacy of ECT-augmented clozapine treatment against other typical and atypical antipsychotics. The Forest Plot revealed that the overall standard mean difference was 0.891 for non-clozapine studies and 1.504 for clozapine studies, at a 95% interval. Furthermore, the heterogeneity plots showed that while clozapine studies showed no significant heterogeneity, non-clozapine studies showed an I2 statistic value at 42.19%, suggesting moderate heterogeneity. Lastly, publication bias showed asymmetrical plots and significant values of Kendal's tau and Egger's rank test. CONCLUSION: ECT augmentation technique was found to be effective in the reduction of psychometric scale scores, and the resulting improvement was significant. Clozapine maintained its stance as the most effective treatment for Treatment-Resistant Schizophrenia, followed by flupenthixol.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Ahmed, S., Khan, A., Mekala, H. M., Venigalla, H., Ahmed, R., Etman, A., Esang, M., & Qureshi, M. (2017). Combined use of electroconvulsive therapy and antipsychotics (both clozapine and non-clozapine) in treatment resistant schizophrenia: A comparative meta-analysis. Heliyon, 3(11), e00429. https://doi.org/10.1016/j.heliyon.2017.e00429

MLA 9

Ahmed, Saeed, et al. “Combined use of electroconvulsive therapy and antipsychotics (both clozapine and non-clozapine) in treatment resistant schizophrenia: A comparative meta-analysis.” Heliyon, vol. 3, no. 11, 2017, p. e00429. https://doi.org/10.1016/j.heliyon.2017.e00429.

Chicago

Ahmed, Saeed, Ali Khan, Hema Madhuri Mekala, Hema Venigalla, Rizwan Ahmed, Amira Etman, Michael Esang, and Mustafa Qureshi. 2017. “Combined use of electroconvulsive therapy and antipsychotics (both clozapine and non-clozapine) in treatment resistant schizophrenia: A comparative meta-analysis.” Heliyon 3 (11): e00429. https://doi.org/10.1016/j.heliyon.2017.e00429.

Harvard

Ahmed, S. et al. (2017) ‘Combined use of electroconvulsive therapy and antipsychotics (both clozapine and non-clozapine) in treatment resistant schizophrenia: A comparative meta-analysis’, Heliyon, 3(11), p. e00429. doi:10.1016/j.heliyon.2017.e00429.

IEEE

S. Ahmed et al., “Combined use of electroconvulsive therapy and antipsychotics (both clozapine and non-clozapine) in treatment resistant schizophrenia: A comparative meta-analysis,” Heliyon, vol. 3, no. 11, p. e00429, 2017, doi: 10.1016/j.heliyon.2017.e00429.

BibTeX

@article{ahmed2017combined,
  title     = {{Combined use of electroconvulsive therapy and antipsychotics (both clozapine and non-clozapine) in treatment resistant schizophrenia: A comparative meta-analysis}},
  author    = {Ahmed, Saeed and Khan, Ali and Mekala, Hema Madhuri and Venigalla, Hema and Ahmed, Rizwan and Etman, Amira and Esang, Michael and Qureshi, Mustafa},
  journal   = {Heliyon},
  year      = {2017},
  volume    = {3},
  number    = {11},
  pages     = {e00429},
  doi       = {10.1016/j.heliyon.2017.e00429},
  url       = {https://doi.org/10.1016/j.heliyon.2017.e00429}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201877
201988
202066
202155
202255
202333
202444
202588
202633

Its field-weighted citation impact is 4.01: it has been cited 4.01 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies

  • treatment-resistant schizophrenia
  • electroconvulsive therapy
  • clozapine
  • antipsychotic augmentation
  • typical antipsychotics
  • atypical antipsychotics
  • psychotic symptoms
  • positive and negative symptoms

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Ahmed, S., Khan, A., Mekala, H. M., Venigalla, H., Ahmed, R., Etman, A., Esang, M., & Qureshi, M. (2017). Combined use of electroconvulsive therapy and antipsychotics (both clozapine and non-clozapine) in treatment resistant schizophrenia: A comparative meta-analysis. Heliyon, 3(11), e00429. https://doi.org/10.1016/j.heliyon.2017.e00429

How many times has this paper been cited?

50 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Heliyon: sign in and open the full text from this page.

Who wrote this paper?

Saeed Ahmed, Ali Khan, Hema Madhuri Mekala, Hema Venigalla, Rizwan Ahmed, Amira Etman, Michael Esang, Mustafa Qureshi.

What is the DOI of this paper?

10.1016/j.heliyon.2017.e00429, permanently at https://doi.org/10.1016/j.heliyon.2017.e00429. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.